SUPRIYA

Supriya Lifescience Share Price

 

 

Invest in Supriya Lifescience with 2.89X leverage

Invest with MTF

Performance

  • Low
  • ₹740
  • High
  • ₹762
  • 52 Week Low
  • ₹556
  • 52 Week High
  • ₹842
  • Open Price₹753
  • Previous Close₹752
  • Volume41,179

Investment Returns

  • Over 1 Month -0.72%
  • Over 3 Month + 1.79%
  • Over 6 Month + 4.66%
  • Over 1 Year + 0.31%

Smart Investing Starts Here Start SIP with Supriya Lifescience for Steady Growth!

Invest Now

Supriya Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 32.7
  • PEG Ratio
  • 2.1
  • Market Cap Cr
  • 5,973
  • P/B Ratio
  • 5.5
  • Average True Range
  • 21.18
  • EPS
  • 22.66
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -3.18
  • RSI
  • 53
  • MFI
  • 64.36

Supriya Lifescience Financials

Supriya Lifescience Technicals

EMA & SMA

Current Price
₹742.10
-9.4 (-1.25%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹742.77
  • 50 Day
  • ₹741.67
  • 100 Day
  • ₹729.42
  • 200 Day
  • ₹702.79

Resistance and Support

744.68 Pivot Speed
  • R3 788.97
  • R2 771.93
  • R1 761.72
  • S1 734.47
  • S2 717.43
  • S3 707.22

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Supriya Lifescience is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) with over 38 APIs across various therapeutic segments. It exports to 86 countries, supplying high-quality APIs for pharmaceuticals, nutraceuticals, and personal care industries.

Supriya Lifescience has an operating revenue of Rs. 714.66 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 36% is great, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 65 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 44 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Supriya Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results
2025-08-13 Quarterly Results
2025-05-27 Audited Results & Final Dividend
2025-03-10 Others Inter-alia, to consider 1. Appointment of Company Secretary and Compliance Officer of the Company. 2. Other business matters. per share(30%)Final Dividend
2025-01-24 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
Date Purpose Remarks
2025-09-05 FINAL Rs.1.00 per share(50%)Final Dividend
View Supriya Lifescience Dividend History Arrow

Supriya Lifescience F&O

Supriya Lifescience Shareholding Pattern

68.3%
0.68%
2.36%
5.46%
0%
16.77%
6.43%

About Supriya Lifescience

  • NSE Symbol
  • SUPRIYA
  • BSE Symbol
  • 543434
  • Managing Director
  • Ms. Saloni Satish Wagh
  • ISIN
  • INE07RO01027

Similar Stocks to Supriya Lifescience

Supriya Lifescience FAQs

Supriya Lifescience share price is ₹742 As on 01 January, 2026 | 11:47

The Market Cap of Supriya Lifescience is ₹5972.6 Cr As on 01 January, 2026 | 11:47

The P/E ratio of Supriya Lifescience is 32.7 As on 01 January, 2026 | 11:47

The PB ratio of Supriya Lifescience is 5.5 As on 01 January, 2026 | 11:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23